Edition:
United States

People: Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

673.00INR
9 Dec 2016
Change (% chg)

Rs-2.55 (-0.38%)
Prev Close
Rs675.55
Open
Rs679.95
Day's High
Rs682.15
Day's Low
Rs671.00
Volume
335,028
Avg. Vol
420,141
52-wk High
Rs898.00
52-wk Low
Rs572.40

Shanghvi, Dilip 

Shri. Dilip Shantilal Shanghvi is Managing Director, Executive Director of Sun Pharmaceutical Industries Limited. He resigned as Executive Chairman of the Board of the Company, effective May 28, 2012. He is a graduate from Calcutta University and has launched Sun Pharma in 1982 and carries industrial experience in the Pharmaceutical industry and at present he is the Chairman and Managing Director of the Company. His other directorships includes: Caraco Pharmaceutical Laboratories Ltd., Detroit, USA, Sun Speciality Chemicals Pvt. Ltd., Sun Resins & Polymers Pvt. Ltd., Sun Fastfin Services Pvt. Ltd., Sun Petrochemicals Private Limited, SPARC Bio-Research Private Limited, Sun Pharma Global Inc., British Virgin Island, Sun Pharma De Mexico SA DE CV, SPIL De Mexico SA DE CV and Shantilal Shanghvi Foundation.

Basic Compensation

Total Annual Compensation, INR 26,545,700
Restricted Stock Awards, INR --
Long-Term Incentive Plans, INR --
All Other, INR 4,980,670
Fiscal Year Total, INR 31,526,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Israel Makov

499,835

Uday Baldota

--

Sunil Ajmera

--

Dilip Shanghvi

31,526,400

Sailesh Desai

10,989,300

Sudhir Valia

31,340,100
As Of  30 Mar 2015